Polymer free Hydroxyapatite coated Sirolimus Eluting Coronary Stent System
- UID
- MFG/MD/2019/000008_6fe54519b39bd65e1cbb3277b234f344_29a838d528b5e8cccd9e594da3d7816b
- Device class
- Class D
- Brand name
- Vestasync Sirolimus Eluting Coronary Stent System
- License holder
- PURPLE MICROPORT CARDIOVASCULAR PRIVATE LIMITED
- Approving authority
- Central Drug Standards Control Organization, Ahmedabad
- Product information
- Product is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease in de novo coronary artery lesion in native coronary arteries in patients eligible for percutaneous Transluminal Coronary Angioplasty (Vestasync Sirolimus Eluting Coronary Stent System)
Polymer free Hydroxyapatite coated Sirolimus Eluting Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2019/000008_6fe54519b39bd65e1cbb3277b234f344_29a838d528b5e8cccd9e594da3d7816b. This device is marketed under the brand name Vestasync Sirolimus Eluting Coronary Stent System. The license holder is PURPLE MICROPORT CARDIOVASCULAR PRIVATE LIMITED, and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, Ahmedabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.